Reviews Write New Review
[email protected]
Paul Hastings
Chairman and Chief Executive Officer, OncoMed Pharmaceuticals
Mr. Hastings is the Chairman and CEO of OncoMed Pharmaceuticals. Prior to joining OncoMed in 2006, Mr. Hastings was President and Chief Executive Officer of QLT, Inc. Previous to that, Mr. Hastings served as President and Chief Executive Officer of Axys Pharmaceuticals, which was acquired by Celera Corporation in 2001. From 1999 to 2001, Mr. Hastings served as the President of Chiron BioPharmaceuticals, a division of Chiron Corporation. Prior to that, he was President and Chief Executive Officer of LXR Biotechnology. Mr. Hastings also held a series of management positions of increasing responsibility at Genzyme Corporation, including serving as President of Genzyme Therapeutics Europe as well as President, Genzyme Therapeutics. Mr. Hastings also served as Vice President, Marketing and Sales and General Manager, Europe for Synergen, Inc., and previously held a series of marketing and sales management positions with Hoffmann-La Roche.
Mr. Hastings was recently Chairman of the Board of Proteolix (sold to Onyx Pharmaceuticals in 2010), and served on the boards of ViaCell (sold to Perkin-Elmer in 2007). He is currently on the boards of Pacira Pharmaceuticals and Relypsa and serves as Chairman of the Emerging Companies Section of the Biotechnology Industry Organization, and was Chairman of the Bay Area Biosciences Association (BayBio).
Mr. Hastings received a Bachelor of Science degree in pharmacy from the University of Rhode Island.
Related Speakers View all
Jerry Avorn
Professor of Medicine at Harvard Medical School; Stu...
|
|
Francois Nader
President and CEO of NPS Pharmaceuticals
|
|
Christopher Austin
Senior Vice President of Research Technologies at GS...
|
|
Matthew Herper
Senior Writer, Medicine & Editorial Director, Events...
|
|
Morris Birnbaum
Senior Vice President and Chief Scientific Officer o...
|
|
Greg Friberg
Vice President, Global Development for Oncology, Amgen
|
|
Peter Hotez
Dean & President of the National School of Tropical ...
|
|
Ben Heywood
Co-Founder and President at PatientsLikeMe
|
|
Bennett Levitan
Director of Epidemiology at Janssen R&D Pharmaceutic...
|
|
Henry Greely
Professor of Law & Genetics at Stanford University
|
|
Stefano Pessina
Executive Vice Chairman & CEO of Walgreens Boots All...
|
|
Toby Cosgrove
Executive Advisor & Former CEO & President at Clevel...
|
|
David C. Magnus
Associate Professor of Pediatrics and Medicine, Stan...
|
|
Dr. Francis Collins
Groundbreaking Geneticist; National Institutes of He...
|
|
Elliot Krane
Expert on Phenomenon of Chronic Pain
|
|
Anthony Atala
Director, Wake Forest Institute for Regenerative Med...
|
|
Edward M. Schaeffer, M.D., Ph.D.
Internationally Recognized Urologist & Prostate Canc...
|
|
Jeffrey Bland
Founder & President of Big Bold Health
|
|
Dr. Hosam Zowawi
Infectious Diseases Scientist, Public Health Strateg...
|
|
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|